Cliff Asness's PCVX Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 14,762 shares of Vaxcyte, Inc. (PCVX) worth $681,119, representing 0.00% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in PCVX, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 14,762 shares. Largest reduction occurred in Q1 2025, reducing 17,944 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Vaxcyte (PCVX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Vaxcyte (PCVX) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +14,762 | New Buy | 14,762 | $46.14 |
| Q3 2025 | -6,381 | Sold Out | 0 | $0.00 |
| Q2 2025 | -191 | Reduce 2.91% | 6,381 | $32.51 |
| Q1 2025 | -17,944 | Reduce 73.19% | 6,572 | $37.76 |
| Q4 2024 | +13,403 | Add 120.61% | 24,516 | $81.86 |
| Q3 2024 | +253 | Add 2.33% | 11,113 | $114.27 |
| Q2 2024 | +328 | Add 3.11% | 10,860 | $75.51 |
| Q1 2024 | -1,568 | Reduce 12.96% | 10,532 | $68.31 |
| Q4 2023 | -400 | Reduce 3.20% | 12,100 | $62.80 |
| Q3 2023 | -1,870 | Reduce 13.01% | 12,500 | $50.98 |
| Q2 2023 | +1,627 | Add 12.77% | 14,370 | $49.94 |
| Q1 2023 | +1,306 | Add 11.42% | 12,743 | $37.48 |
| Q4 2022 | +2,111 | Add 22.64% | 11,437 | $47.95 |
| Q3 2022 | +9,326 | New Buy | 9,326 | $24.02 |
Cliff Asness's Vaxcyte Investment FAQs
Cliff Asness first purchased Vaxcyte, Inc. (PCVX) in Q3 2022, acquiring 9,326 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Vaxcyte, Inc. (PCVX) for 14 quarters since Q3 2022.
Cliff Asness's largest addition to Vaxcyte, Inc. (PCVX) was in Q4 2025, adding 14,762 shares worth $681,119.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 14,762 shares of Vaxcyte, Inc. (PCVX), valued at approximately $681,119.
As of the Q4 2025 filing, Vaxcyte, Inc. (PCVX) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Vaxcyte, Inc. (PCVX) was 24,516 shares, as reported at the end of Q4 2024.